Nicolae Bacalbasa1, Irina Balescu2. 1. Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania nicolae_bacalbasa@yahoo.ro. 2. Department of General Surgery, Ponderas Academic Hospital, Bucharest, Romania.
Abstract
BACKGROUND: Most cases with advanced-stage epithelial ovarian malignancies will experience recurrent disease at a certain moment of their evolution, even if maximal cytoreductive surgery has been performed at the moment of initial diagnosis. However, it seems that the best therapeutic strategy, in case of relapse, remains aggressive re-resection, with complete cytoreduction being the most efficient way to improve survival. MATERIALS AND METHODS: We present the case of a 55-year-old patient diagnosed with an isolated pelvic recurrence after stage IIIC surgically-treated ovarian cancer three years after primary cytoreduction. RESULTS: Intraoperatively, the diagnosis of an isolated pelvic recurrence invading the urinary bladder was confirmed. The recurrent tumor was resected en bloc with partial cystectomy. The postoperative course was uneventful, while histopathological studies confirmed the presence of a poorly differentiated epithelial ovarian recurrent adenocarcinoma. At two year follow-up, the patient is free of any recurrent disease. CONCLUSION: Isolated pelvic recurrences after surgically-treated ovarian adenocarcinomas can be safely removed and might improve survival. Copyright
BACKGROUND: Most cases with advanced-stage epithelial ovarian malignancies will experience recurrent disease at a certain moment of their evolution, even if maximal cytoreductive surgery has been performed at the moment of initial diagnosis. However, it seems that the best therapeutic strategy, in case of relapse, remains aggressive re-resection, with complete cytoreduction being the most efficient way to improve survival. MATERIALS AND METHODS: We present the case of a 55-year-old patient diagnosed with an isolated pelvic recurrence after stage IIIC surgically-treated ovarian cancer three years after primary cytoreduction. RESULTS: Intraoperatively, the diagnosis of an isolated pelvic recurrence invading the urinary bladder was confirmed. The recurrent tumor was resected en bloc with partial cystectomy. The postoperative course was uneventful, while histopathological studies confirmed the presence of a poorly differentiated epithelial ovarian recurrent adenocarcinoma. At two year follow-up, the patient is free of any recurrent disease. CONCLUSION: Isolated pelvic recurrences after surgically-treated ovarian adenocarcinomas can be safely removed and might improve survival. Copyright
Authors: A Munkarah; C Levenback; J K Wolf; D Bodurka-Bevers; G Tortolero-Luna; R T Morris; D M Gershenson Journal: Gynecol Oncol Date: 2001-05 Impact factor: 5.482
Authors: Dennis S Chi; Kristina McCaughty; John P Diaz; Jae Huh; Sarah Schwabenbauer; Amanda J Hummer; Ennapadam S Venkatraman; Carol Aghajanian; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat Journal: Cancer Date: 2006-05-01 Impact factor: 6.860
Authors: P Harter; M Hahmann; H J Lueck; M Poelcher; P Wimberger; O Ortmann; U Canzler; B Richter; U Wagner; A Hasenburg; A Burges; S Loibl; W Meier; J Huober; D Fink; W Schroeder; K Muenstedt; B Schmalfeldt; G Emons; A du Bois Journal: Ann Surg Oncol Date: 2009-02-19 Impact factor: 5.344
Authors: Chee Khoon Lee; Sarah Lord; Tami Grunewald; Val Gebski; Anne-Claire Hardy-Bessard; Jalid Sehouli; Kathrine Woie; Mark Heywood; Christian Schauer; Ignace Vergote; Giovanni Scambia; Annamaria Ferrero; Philipp Harter; Eric Pujade-Lauraine; Michael Friedlander Journal: Gynecol Oncol Date: 2014-10-02 Impact factor: 5.482